Department of Pharmacology, KMCH College of Pharmacy, Coimbatore, Tamil Nadu, India.
Asian Pac J Trop Med. 2011 Aug;4(8):624-31. doi: 10.1016/S1995-7645(11)60160-0.
To investigate antidiabetic, antihyperlipidemic and antioxidant activity of methanol extract of Tectona grandis (T. grandis) flowers (METGF) in streptozotocin (STZ) induced diabetic rats to supports its traditional use.
Acute toxicity study of METGF was carried out in rat to determine its dose for the antidiabetic study. Oral glucose tolerance test (OGTT) was performed to evaluate METGF effect on elevated blood glucose level. Diabetes was induced in rats by administration of STZ (60 mg/kg, ip.) and it was confirmed 72 h after induction. METGF was orally given to the diabetic rats up to 28 days and blood glucose level were estimated each week. On 28 day of the experiment, diabetic rats were sacrificed after the blood collection for the biochemical parameters analysis and liver, kidney was collected to determine antioxidants levels.
In acute toxicity, METGF did not show toxicity and death up to a dose 2 000 mg/kg in rats. Administration of METGF 100 and 200 mg/kg significantly (P<0.001) reduced blood glucose levels in OGTT and STZ-induced diabetic rats. Both doses of METGF treatment significantly (P<0.001, P<0.01 and P<0.05) increased body weight, serum insulin, haemoglobin (Hb) and total protein levels in diabetic rats. Also, MEGTF treatment reduced elevated glycosylated haemoglobin (HbA1c) and other biochemical parameters levels significantly (P<0.001) in diabetic rats. Altered lipid profiles and antioxidants levels were reversed to near normal in diabetic rats treated with METGF.
These results concluded that METGF possesses antidiabetic, antihyperglycemic and antioxidant activity which supports its traditional use.
研究柚花木花甲醇提取物(METGF)在链脲佐菌素(STZ)诱导的糖尿病大鼠中的降血糖、降血脂和抗氧化活性,以支持其传统用途。
在大鼠中进行 METGF 的急性毒性研究,以确定其用于糖尿病研究的剂量。进行口服葡萄糖耐量试验(OGTT)以评估 METGF 对升高的血糖水平的影响。通过给予 STZ(60mg/kg,ip.)诱导大鼠糖尿病,并在诱导后 72 小时确认。METGF 以口服方式给予糖尿病大鼠,持续 28 天,并每周评估血糖水平。在实验的第 28 天,在收集血液进行生化参数分析和收集肝脏、肾脏以确定抗氧化剂水平后,处死糖尿病大鼠。
在急性毒性中,METGF 在大鼠中剂量高达 2000mg/kg 时没有显示毒性和死亡。METGF 100 和 200mg/kg 给药显著(P<0.001)降低了 OGTT 和 STZ 诱导的糖尿病大鼠的血糖水平。两种剂量的 METGF 治疗均显著(P<0.001、P<0.01 和 P<0.05)增加了糖尿病大鼠的体重、血清胰岛素、血红蛋白(Hb)和总蛋白水平。此外,METGF 治疗显著降低了糖尿病大鼠升高的糖化血红蛋白(HbA1c)和其他生化参数水平(P<0.001)。METGF 治疗使糖尿病大鼠改变的脂质谱和抗氧化剂水平恢复到接近正常。
这些结果表明,METGF 具有降血糖、降血糖和抗氧化活性,支持其传统用途。